Else Nutrition to Report Third Quarter 2022 Financial Results on November 14, 2022
08 November 2022 - 12:00AM
ELSE NUTRITION HOLDINGS INC
(BABY)
(BABYF)
(0YL.F) ("Else" or the "Company") the
Plant-Based baby, toddler, and children nutrition company,
announced today that it expects to report third-quarter 2022
financial results for the period ending September 31, 2022, on
November 14, 2022. The Company has scheduled a conference call on
November 14th, at 10:00 a.m. ET, to discuss the results.
Interested parties can access the conference
call via Internet webcast, which is available in the Investors
section of the Company’s website at
https://elsenutrition.com/pages/investor-relations or at
https://app.webinar.net/AMgJ03EoQNW.
Interested parties who would like to submit a
question to be addressed on the call should email the question
to shamsian@lythampartners.com.
A webcast replay will be available in the
Investors section of the Company’s website at
https://elsenutrition.com/pages/investor-relations or via
https://app.webinar.net/AMgJ03EoQNW.
About Else Nutrition Holdings
Inc.
Else Nutrition GH Ltd. is an Israel-based food
and nutrition company focused on developing innovative, clean and
plant-based food and nutrition products for infants, toddlers,
children, and adults. Its revolutionary, plant-based, non-soy,
formula is a clean-ingredient alternative to dairy-based formula.
Else Nutrition (formerly INDI) won the "2017 Best Health and Diet
Solutions" award at the Global Food Innovation Summit in Milan.
Else Plant-Based Complete Nutrition for Toddlers was recently
ranked as the #1 Top seller in the baby and toddler formula
category on Amazon. The Company recently received the World
Plant-Based Award for “Best dairy alternative product” in New York
at World Plant-Based Expo in late 2021. The holding company, Else
Nutrition Holdings Inc., is a publicly-traded company, listed as
Toronto Stock Exchange under the trading symbol BABY and is quoted
on the US OTC Markets QX board under the trading symbol BABYF and
on the Frankfurt Exchange under the symbol 0YL.
Else's Executives include leaders hailing from leading
infant nutrition companies. Many of Else’s advisory board members
had past executive roles in companies such as Mead Johnson, Abbott
Nutrition, Plum Organics, and leading infant nutrition
Societies, and some of them currently serve in different
roles in leading medical centers and academic institutes such as
Boston Children's Hospital, Pediatrics at Harvard Medical School,
USA, Tel Aviv University, Schneider Children's Medical Center of
Israel, Rambam Medical Center and Technion, Israel and University
Hospital Brussels, Belgium.
For more information,
visit: elsenutrition.com or @elsenutrition on Facebook
and Instagram.
Investor Relations
Contact:Lytham Partners, LLCMr. Ben ShamsianNew York |
PhoenixE: shamsian@lythampartners.comP: 646-829-9701
Toronto Stock Exchange
Neither the Toronto Stock Exchange nor its
regulation services provider (as that term is defined in the
policies of the Toronto Stock Exchange) a responsibility for the
adequacy or accuracy of this release.
Caution Regarding Forward-Looking
Statements
This press release contains statements that may
constitute “forward-looking statements” within the meaning of
applicable securities legislation. Forward-looking statements are
typically identified by words such as “will” or similar
expressions. Forward-looking statements in this press release
include statements with respect to the anticipated dates for filing
the Company’s financial disclosure documents. Such forward-looking
statements reflect current estimates, beliefs and assumptions,
which are based on management’s perception of current conditions
and expected future developments, as well as other factors
management believes are appropriate in the circumstances. No
assurance can be given that the foregoing will prove to be correct.
Forward-looking statements made in this press release assume, among
others, the expectation that there will be no interruptions or
supply chain failures as a result of COVID 19 and that the
manufacturing, broker and supply logistic agreement with the
Company do not terminate. Actual results may differ from the
estimates, beliefs and assumptions expressed or implied in the
forward-looking statements. Readers are cautioned not to place
undue reliance on any forward-looking statements, which reflect
management’s expectations only as of the date of this press
release. The Company disclaims any obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise, except as required by
law.
Else Nutrition (TSX:BABY)
Historical Stock Chart
From Mar 2024 to Apr 2024
Else Nutrition (TSX:BABY)
Historical Stock Chart
From Apr 2023 to Apr 2024